Introduction
============

According to World Health Organization, *flaviviruses* are responsible for serious outbreaks world wide and hence considered as global health burden^[1](#fn01){ref-type="fn"}^ ([@B28]; [@B49]). For example, the epidemics by dengue virus, DENV (100 countries in Africa, the Eastern Mediterranean, the Americas, the Western Pacific, and South-East Asia), Zika virus, ZIKV (in 42 countries), Yellow fever virus, YFV (Angolan capital city, China), and many more are reported recently. They comprise arboviruses, which are known for their shifting epidemiology in response to the changing societal factors, e.g., population growth and urbanization ([@B34]). Among all the mosquito species, the *Aedes* mosquito species are known to have prominent role in *flaviviruses* transmission, due to their ability to thrive in diverse ecological niche (beyond their resident tropical forest niche).

The genome of *flaviviruses* comprises positive-sense, non-segmented single-stranded RNA, which ranges from 9.0 to 13 kb ([@B42]). It code for single long open reading frame (ORF), being flanked by 5′ end (methylated nucleotide cap) and 3′ end (non-polyadenylated) and forms secondary structures for genome replication ([@B4]). Further, the ORF codes for single large polyprotein, which is processed by host proteases and resulted in 10 proteins including structural (3) and non-structural (7). The three structural proteins are capsid (C), premembrane/membrame (prM/M), and envelop (E), whereas the seven non-structural proteins are NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5 ([@B3]).

Various inhibitors like chemicals, peptides, and peptidomimetics have been designed against the *flaviviruses* to target their stages and proteins. For example, NITD-448 ([@B30]) inhibits E protein-mediated membrane fusion, P02 hampers the viral replication ([@B53]), in DENV. The DN59 inhibits the flaviviral infection by interacting with viral particles ([@B31]); ST-148 is an active compound against all four DENV serotypes ([@B7]); BP13944 ([@B50]), keto amides ([@B44]), is known as dengue protease inhibitor; ivermectin targets the helicase activity of DENV, YFV, and JEV ([@B32]; [@B27]). Further, the NITD-618 is an effective NS4B inhibitor against all DENV serotypes ([@B30]); ribavirin impedes the DENV methyltransferase and HCV replication ([@B10]; [@B47]). Moreover, the NITD 008 and NITD 203 are RNA-dependent RNA polymerase inhibitors and target all the four serotype of DENV, WNV, and YFV ([@B8]). Lycorine displays the antiviral activity against many *flaviviruses* like YFV, WNV, and DENV-1 ([@B20]; [@B8]). Despite several inhibitors tested, only a few are proved efficient against the circulating mutant strains of viruses.

In literature, limited computational resources are available for predicting antiviral potential of any compound. Our group has been developing various web servers *viz.* AVPpred for predicting the effective antiviral peptides ([@B46]), AVP-IC50Pred dedicated to identify the antiviral activity of a peptide based on the half life inhibitory concentration ([@B37]). Likewise, AVCpred platform was designed to predict general antiviral compounds ([@B35]) and HIVProtI for predicting and designing inhibitors specifically against Human Immunodeficiency Virus proteins ([@B36]). Since, *flaviviruses* have been emerged as worldwide threat, affecting more than 50% population globally (∼40% infected by DENV alone) ([@B22]). Therefore, there is a need to accelerate the development of efficient therapeutics. Hence, in current study we are providing *anti-flavi*, a web platform for prediction and designing of novel antiviral compounds specifically against *flaviviruses*.

Materials and Methods {#s1}
=====================

Data Collection
---------------

For the development of predictive models, the flaviviral inhibitors were extracted from ChEMBL database ([@B18]), whereas the anti-flaviviral peptides were retrieved from AVPdb database ([@B38]). The ChEMBL is a comprehensive repository, which contains manually curated bioactive molecules possessing drug-like properties. It has been previously utilized for development of various algorithms, e.g., AVCpred ([@B35]), HIVProtI ([@B36]), CLC-Pred ([@B26]), and Pred-hERG ([@B6]). The AVPdb database is a comprehensive database of experimentally verified antiviral peptides (AVPs) and was earlier utilized for various algorithm like AVP-IC~50~Pred ([@B37]).

In the current study, we fetched the data for the inhibitors (chemicals and peptides) designed to "target" whole "organism." The chemicals against whole organism were extracted by using specific keywords like "Dengue virus," "Hepatitis C virus," "West Nile Virus," "Yellow Fever virus," and "Japanese encephalitis virus." Majority of the inhibition profile was reported in the form of half maximal inhibitory concentration, i.e., IC~50~, therefore we preceded our study with it. Likewise the anti-flaviviral peptides were extracted from AVPdb database with inhibition profile as the half maximal inhibitory concentration.

Initially, we obtained 65, 2038, 33, 22, 10 inhibitors against DENV (serotype 1--4), HCV, WNV, YFV, and JEV whereas 117 unique anti-flaviviral peptides. Finally, after filtering the anti-flaviviral inhibitors with relevant information and removing the redundant entries we acquired 2168 chemicals and 117 peptides (length 7 to 25 amino acids), respectively. The regression-based models were constructed on the negative logarithm of half maximal inhibitory concentration (pIC~50~ = -log~10~ (IC~50~(M))) ([@B24]; [@B52]; [@B2]). For the development of prediction algorithm, the complete dataset was sub-divided (in triplicate) into training/testing (90%) and independent validation (10%) sets. Later, out of the three, one of the dataset set was used for algorithm development.

Quantitative Structure Activity Relationship Based Model Development
--------------------------------------------------------------------

The quantitative structure--activity relationship (QSAR) is a mathematical relationship between a biological activity and physiochemical property of any compound ([@B11]). It uses various descriptors that represent the chemical characteristics of a molecule in numerical form, i.e., 1D, 2D, and 3D. We utilized the PaDEL software to extract out various molecular descriptors and fingerprints ([@B51]). Further, the descriptors were used for model development of anti-flaviviral compounds. Initially, the PaDEL resulted in 16384 descriptors included in 2D, 3D, and fingerprints categories. This strategy was further employed for the algorithm development in various previous studies ([@B35], [@B36]; [@B40]).

Format Conversion
-----------------

We performed format conversion before extracting the PaDel descriptors, in order to get the 3D descriptors along with 2D and fingerprints. In case of chemicals, the retrieved SMILES from ChEMBL were translated to SDF format through obabel software ([@B33]). Whereas the anti-flavi peptides were in the form of amino acid sequences, which were firstly converted to pdb using pepstrmod ([@B43]) software with length 7 to 25 amino acids. Later on the pdbs were converted to SDF format using obabel software. We proceeded for the pdb to sdf conversion because the pdb format does not providing the complete descriptors as compared to sdf of the peptides.

Ten-Fold Cross Validation
-------------------------

Initially, the model was developed on the training/testing by sub grouping into 10 almost equal parts. Of the 10 subgroups, single part is retained for testing while remaining nine was utilized for training purpose. This process was iterated 10 times, and every subgroup got the chance to be testing dataset. Further, for checking the performance of developed model the accuracy of all the 10 iterations were averaged out ([@B39]; [@B45]). Finally, the developed model on training/testing data set was cross-evaluated independent validation dataset.

Support Vector Machine
----------------------

For developing the regression-based predictive models, we used support vector machine (SVM) learning algorithm ([@B21]). In regression mode, the SVM works on defining the function (the loss function/epsilon intensive), which ignores errors and situated within the specific distance boundaries of the actual value ([@B5]). The support vector regression (SVR) is of two types, i.e., linear and non-linear. However, the non-linear SVR is much more complex as it employed kernel approach to address curse of the dimensionality. We employed SVM*^light^* module of support vector machine to develop all the models.

Random Forest
-------------

Random forest (RF) is an ensemble-learning method that works on the basis of decision tree model with bootstrapping algorithm. First, the decision tree was made from training data sets and the classes of unknown sample is assigned either according to the mode of classes in classification or mean prediction for regression based data sets. RF was used through Waikato Environment for Knowledge Analysis (WEKA) package in prediction model development ([@B15]).

Feature Selection
-----------------

Feature selection is an important technique to extract out the best contributing features from the existing features. We implemented WEKA package for feature selection, initially the RemoveUseless filter were used for preprocessing. Further, the attributes were selected through CFsSubsetEval (*attribute evaluator*) and BestFirst (*search method*) ([@B15]). Finally, we got best representative features (relevant) for all the models.

Performance Measure
-------------------

The performance of the QSAR developed models was evaluated using correlation coefficient (R, PCC).

*Pearson's correlation coefficient* (*R*) or bivariate correlation determine the association between two variables (actual and predicted) and calculated by the formula:
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Its value ranges from +1 to -1, +1 means the two variables are positively correlated whereas -1 depicts the negative correlation between two variables, here, *n*, ![](fmicb-09-03121-e001.jpg), and ![](fmicb-09-03121-e002.jpg)ct are size of the data set, predicted, and actual efficiencies.

Model Performance
-----------------

We checked the appropriateness of the developed models by plotting the actual v/s predicted inhibition ([@B36]). The plot was constructed on the actual and predicted values of training/testing as well as independent validation data sets. The scatter plot was used to depict the relationship between both the values. The best predictive ability of model is depicted by the localization of the points of actual and predicted values on/nearest to the trend line.

Decoy Set
---------

We used decoy set to check the robustness of our developed models. There were few tools like DUD ([@B23]), DecoyFinder ([@B9]), and RADER ([@B48]) for designing the decoys of the chemicals. In our study, the decoys were generated from the latest tool, i.e., RApid DEcoy Retriever (RADER) software ([@B48]) against the 2168 anti-flavi chemicals with similar 1D physicochemical properties but different 2D topology.

Clustering
----------

We performed clustering using ChemMine tool ([@B1]). We used multidimensional scaling clustering method by both 2D and 3D method with cutoff similarity of 0.4. However, the clustering of the peptide sequences was dome using CLuster ANalysis of Sequences (CLANS) software ([@B16]), which performs *all-against-all* BLAST search.

Results
=======

Feature Selection
-----------------

The 16,384 features of anti-flavi chemicals and peptides were subjected to feature selection, which resulted in 8700 and 3822 features for chemicals and peptides, respectively, after the preprocessing by RemoveUseless filter. Further, the 8700 and 3822 features were processed using CfssubsetEval and BestFirst attribute selector and reduced to 124 and 19 features against chemicals and peptides correspondingly. The detailed information of all the selected descriptors of chemicals and peptides are provided in **Supplementary Tables [S1](#SM1){ref-type="supplementary-material"}**, **[S2](#SM1){ref-type="supplementary-material"}**, respectively. The models were developed using these reduced and relevant features.

Performance of QSAR-Based Models
--------------------------------

The 2168 anti-flavi chemicals were divided into training/testing and independent validation data sets with 1952 and 216 sequences, respectively, through randomization method. The best performing model displayed the correlation of 0.87 and 0.87 through SVM and RF machine learning technique during 10-fold cross-validation (**Table [1](#T1){ref-type="table"}**). Whereas, the independent validation data set showed the correlation of 0.87 and 0.86 correspondingly with developed model during the cross-validation through SVM and RF techniques (detailed in **Supplementary Table [S3](#SM1){ref-type="supplementary-material"}**).

###### 

Performance of training/testing and independent validation data sets of anti-flavi chemicals and peptides on 10-fold cross validation using Support Vector Machine and Random Forest techniques.

                                  Training/testing   Independent validation          
  ----------- ------- ----- ----- ------------------ ------------------------ ------ ---------------
  Chemicals   16383   124   SVM   0.87               TESTSET = 1952           0.87   TESTSET = 216
  Peptides    16383   19    SVM   0.84               TESTSET = 105            0.84   TESTSET = 12
  Chemicals   16383   124   RF    0.87               TESTSET = 1952           0.86   TESTSET = 216
  Peptides    16383   19    RF    0.83               TESTSET = 105            0.86   TESTSET = 12

SVM, support vector machine; RF, random forest; PCC, Pearson's correlation coefficient

.

The 117 anti-flavi peptides were grouped into 112 sequences as training/testing and 15 as independent validation data sets. Out of the three randomized models, the best one achieved correlation of 0.84 and 0.83, respectively, using SVM and RF techniques during 10-fold cross-validation on training/testing data sets (**Table [1](#T1){ref-type="table"}**). While, the independent validation data set displayed the correlation of 0.84 and 0.86 correspondingly on RF and SVM techniques (detailed in **Supplementary Table [S4](#SM1){ref-type="supplementary-material"}**).

Model Performance
-----------------

We checked the robustness of the model by plotting actual v/s predicted value and residual plot of residuals v/s predicted values on independent validation data set of both chemical and peptides. The experimental v/s predicted values of independent validation dataset are shown in **Figure [1](#F1){ref-type="fig"}**. The plot between actual and predicted inhibition displayed the statistical significance among the pIC50 of the model on independent data sets. Maximum points found to be lie close to the origin, which shows that the model developed using training/testing data sets are robust. The scatter plot for actual v/s predicted of independent validation data set using SVM technique is provided in **Figure [1](#F1){ref-type="fig"}**. However, the scatter plot for actual v/s predicted inhibition efficiency of independent validation data set using RF technique is available in **Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**. Further, the residual plot also prove the robustness of the developed model as maximum points exist close to the origin line as shown in SVM (**Figure [2](#F2){ref-type="fig"}**) and RF (**Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}**) models.

![Scatter plot for Actual vs. Predicted inhibition for the independent validation data set on the Support vector machine developed models on **(A)** anti-flavi chemicals and **(B)** anti-flavi peptides.](fmicb-09-03121-g001){#F1}

![Residual plot for Residuals vs. Predicted inhibition for the independent validation data set on the Support vector machine developed models on **(A)** anti-flavi chemicals and **(B)** anti-flavi peptides.](fmicb-09-03121-g002){#F2}

Further, the robustness of the model was checked using decoy data set. We opted top most hit of each 2168 chemicals, which resulted in 1417 decoys. The predicted pIC~50~ of the decoy is ranges from 3.03 to 7.83, as shown in **Supplementary Table [S5](#SM1){ref-type="supplementary-material"}**.

Peptidomimetics Approach
------------------------

We checked the peptidomimetics approach in the anti-flaviviral inhibitors by swapping the most contributing features of and peptides (19) and chemicals (124) among each other along with the hybrid features (143) using 10-fold cross validation through SVM technique. On employing the 124 features of chemicals on 117 anti-flavi peptides and 19 features on 2168 chemicals, we achieved the PCC of 0.53 and 0.74, respectively. Interestingly, on combining the top contributing features of anti-flavi chemicals and peptides, i.e., 143, we got the PCC of 0.83 and 0.87 on chemicals and peptides correspondingly. Detailed results are tabulate in **Table [2](#T2){ref-type="table"}**.

###### 

Table depicting the performance of swapped most-contributing features of chemicals and peptides over each other during 10-fold cross validation employing support vector machine.

  Data        Descriptors   Features   PCC    Dataset
  ----------- ------------- ---------- ------ ----------------
  Chemicals   16383         19         0.74   TESTSET = 2168
  Peptides    16383         124        0.53   TESTSET = 117
  Chemicals   16383         143        0.87   TESTSET = 2168
  Peptides    16383         143        0.83   TESTSET = 117

PCC, Pearson's correlation coefficient; cof-R2, coefficient of determination; RMSE, Root Means Squared Error; MAE, Mean Absolute Error

.

Clustering
----------

We performed clustering of the anti-flavi chemicals and peptides. The clustering displayed that anti-flavi compounds are highly diverse with clustered in 58 different clusters as shown in **Figure [3](#F3){ref-type="fig"}**, with cutoff similarity threshold of 0.4. Additionally, the 2D plot of clusters in provided in **Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}**.

![3-Dimensional plot showing the chemical spacing of 2168 anti-flavi chemicals embedded in 3D space with 58 different clusters.](fmicb-09-03121-g003){#F3}

We also perform clustering of the peptide sequences, to check the diversity in out anti-flavi data sets (as shown in **Figure [4](#F4){ref-type="fig"}**). The *p*-value range for the clustering was set between 1e-90 and 0.1, most of the peptides were singleton. At such a stringent *p*-value we get only 10 clusters, rest sequences were found in unclustered.

![The clustering plot of the 117 anti-flavi peptides showing the clustering pattern at *p-value* 1e-90 and 0.1.](fmicb-09-03121-g004){#F4}

Webserver
---------

*Anti-flavi* integrates SVM and RF predictive models to identify the inhibition efficiency of any chemical or peptides using QSAR-based approaches. For the prediction of anti-flavi chemicals, the user can provide input in form of multiple sdf formats and the output would be available in tabulated form with information of SMILES, 2D structure, important chemical descriptors, and inhibition efficiency. Whereas, for predicting the flaviviral inhibition potential of peptides the input would be provided in form of pdb format, which further led to the output as percentage inhibition of the peptide and other specifications like SMILES, 2-D image, and descriptors. As the calculation of unknown chemicals and peptides usually took 2--5 min, so the user can note the job id and retrieve the results any time using "check job status" page.

The anti-flavi webservers also displayed the clustering analyses of both chemicals and peptides under the "analysis" portion. Moreover, we are also providing the format conversion facility, where the user can draw/paste the structure and get the output in form of SMILES, sdf, and mol format. The overall architecture of the anti-flavi is provided in **Figure [5](#F5){ref-type="fig"}**.

![Architecture of anti-flavi web server.](fmicb-09-03121-g005){#F5}

Discussion
==========

*Flaviviruses* emerged as an expanding threat to human health globally ([@B13]). Various efforts has been made to develop an effective anti-flavi drugs aiming specific replication, structural, non-structural, and host protein, as well as non-specific targets, etc ([@B41]; [@B4]; [@B17]). To tackle the severity of the RNA viruses, the European Union released VIZIER ([@B12]) and SILVER^[2](#fn02){ref-type="fn"}^ projects for drug discovery against viruses. However, various computational efforts would be useful along with the experimental ones to speed up the antiviral drug discovery process. In this regards, the present study is focused to develop first dedicated computational platform against the flavivirus.

We used anti-flavi chemicals and peptides for developing the predictive models. Further, the peptidomimetics approach was also explored in addition to the individual chemicals and peptides. Interestingly, the performance of the developed models on chemicals is more than peptide and peptidomimetics. Additionally robustness of the developed models was also cross checked by plotting actual v/s predicted inhibition values of training/testing and independent validation data set. Finally, the predictive models proved to be statistically significant, which depicts their ability to predict any unknown agent as anti-flaviviral with high efficiency ([@B14]).

The concept of peptidomimetics is evidenced to be successful among the drug inhibitors, few examples of peptidomimetics were also reported against WNV ([@B29]; [@B19]), HIV ([@B25]), etc. Our study also demonstrated the same, as we achieved good performance though most contributing features of chemicals on the peptides and vice versa. Intriguingly, the performance of the models increases when the most contributing features of chemicals and peptides were used together. Therefore, our study suggests that the concept of peptidomimetics can also be implemented in the anti-flaviviral agents.

We evaluated the performance of the models through independent validation and decoy data set. As, the developed predictive models also showed good performance on both independent validation and decoy data set, which further proves their robustness. We also tried to compare our algorithm with existing one, but didn't able to perform direct comparison, due to lack of any method for anti-flaviviral agents.

The diversification of the chemicals and peptides were also explored using different clustering methods for both type of agents. The clustering analyses displayed high level of diversification among the anti-flavi agents at statistically significant conditions. Majority of chemicals and peptides tend to remain un-clustered rather than showing similarity through cluster forming tendency.

The effective inhibitors against *flaviviruses* are the need of the hour. The incorporation of computational approach with experimental one would definitely speed up the process of anti-flavi agents' discovery. We used 10-fold cross validation to develop a robust prediction algorithm, which was further cross validated with independent validation as well as decoy data set. We, first time, incorporate peptidomimetics approach in prediction algorithm against *flaviviruses*. Therefore, this computational method would be highly beneficial to microbiologists and virologists, working hard to develop a novel and effective antiviral agents. This algorithm can be used to filter out the highly effective anti-flavi agents, which can be tested directly in experimental lab, rather than doing initial high through put screening. The limitation of our study is that the predictive models were developed on major flaviviral species rather than all, e.g., HCV, DENV, ZIKV, and WNV.
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